Briefs: Aurobindo Pharma and Balaxi Pharmaceuticals

Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company

Eurofins opens BioPharma campus in Hyderabad

The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies

Briefs: NATCO Pharma, Strides Pharma and Aurobindo Pharma

Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.

Apollo Hospitals launches the latest generation ophthalmology laser machine, FEMTO LDV Z8 from Ziemer

Briefs: Granules India

Granules India received approval from Brazilian Health Regulatory Agency ANVISA

Dr. Agarwal's Health Care raises US$80 mn from TPG and Temasek to expand network to 300 hospitals

The company has new projects in development in Mumbai, Punjab, central and northern India, among others

Health Minister Mandaviya inaugurates the phase II of Mass Drug Administration initiative for Lymphatic Filariasis

India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive

Briefs: Dr. Reddy's Laboratories and Aurobindo Pharma

The inspection closed with zero observations and a classification of No Action Indicated

Upsurge in pink eye conjunctivitis cases in the country

Take proper precautions and seek timely treatment!

Aurobindo Pharma gets 3 observations from USFDA for Unit 3 at Bachupally Village

Aurobindo will respond to the US FDA within the stipulated timelines